PET is Wonderful Annual Meeting
PET is Wonderful Annual Meeting
29 October 2018, South Hall Complex, Pollock Halls, University of Edinburgh
Dr Ralph Paul Maguire
Paul is Senior Director and Molecular Imaging Lead in UCB Pharma Translational Medicine Neuroscience, Braine l’Alleud, Belgium. He received his BSc. from Paisley College of Technology and PhD from University of Surrey, UK and is MIPEM, MInstP and UK clinical scientist. He was previously Director and Head of Clinical Imaging at Novartis Basel, Switzerland and Director of Neuroimaging at Pfizer Global R&D, Groton, US. He has been leading the application of imaging and biomarkers in translational neurosciences for the past 14 years. His research interests include PET-PK modeling, molecular imaging probe development, neuronal activation as a target and mechanism biomarker, and atrophy measurements using structural MRI. In his earlier career 1990 - 2004 Paul was physicist in the PET program, Paul Scherrer Institute PET research program in Villigen, Switzerland, assistant professor and medical physicist at University Medical Center Groningen / University of Groningen. His research publications can be found here.
Dr Gilles D. Tamagnan
Gilles D. Tamagnan, PhD, received his doctorate in medicinal chemistry at the University Joseph Fourier in Grenoble, France in 1993. After a postdoctoral fellowship spent on the crystallization of protein, Dr. Tamagnan completed a second postdoctoral fellowship at RBI in Boston, Massachusetts. His research was focused on developing new radioligands for the diagnosis of Parkinson’s disease, and Dr. Tamagnan is a co-inventor of DatScan. He joined the Neuroimaging Program at Yale University in June 1997 to work on the development of new radioligands to study neurodegenerative diseases. Later he moved to Molecular NeuroImaging (MNI) LLC and the Institute for Neurodegenerative Disorders (IND) in 2003, where he worked as Vice President of Chemistry and Translational Research and Laboratory Research and Development Director for several years. Recently Dr Tamagnan has found and is the current Chief Executive Officer of XingImaging LLC, a company focused on developing new radiotracers and providing imaging services. His research publications can be found here.
Find a downloadable version of the meeting programme attached at the bottom of this page.
Calls now open for:
- PET Poster Abstracts
- Very Important Project (VIP) PET Prize (A chance to win FREE preclinical PET/CT scanning time including radiotracer batch*!)
Instructions on how to submit both posters and competition entries, along with an applicaition form for the PET prize, and terms and conditions for the PET prize can be downloaded from the bottom of this page.
All VIP PET prize applicants must register to attend the meeting before submitting the project proposal via EasyChair and the registration confirmation number must be clearly identified on the application form
* Terms and conditions apply
Deadline for registration, abstract submission, and VIP PET Prize Application: 30 September 2018
- Poster Abstract Decisions to be communicated: 15th October 2018
- VIP PET Winner to be communicated on the day of the meeting: 29th October 2018
Registration and Submissions:
To register for the meeting, please click here
To submit an abstract or apply for the VIP PET Prize, please click here